Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1997-3-20
pubmed:abstractText
In order to investigate the expression of MUC5AC mucin in normal gastric mucosa and gastric carcinomas, we produced 3 monoclonal antibodies (MAbs) using a MUC5AC synthetic peptide. The immunohistochemical study was performed using one of these MAbs (CLH2) which reacted with the different designs of peptides based on the MUC5AC tandem repeat and with native and deglycosylated mucin extracted from gastric tissues. CLH2 immunoreactivity was restricted to foveolar and mucopeptic neck cells in normal gastric mucosa. No reactivity was observed in type-I intestinal metaplasia. Out of 66 gastric carcinomas, 42 (63.6%) expressed MUC5AC. Most diffuse carcinomas were positive (83.3%), whereas only 59.3% of intestinal and 40.0% of atypical carcinomas expressed MUC5AC (p < 0.05). Gastric carcinomas with mixed pattern showed immunoreactivity in diffuse areas and decreased immunoreactivity in intestinal areas. Every early gastric carcinoma expressed MUC5AC, in contrast to 58.6% of advanced carcinomas (p < 0.05). A trend toward decreased immunoreactivity was observed in deep areas of advanced carcinomas in comparison with the respective superficial areas. Taking together the specific staining of foveolar and mucopeptic neck cells and the absence of immunoreactivity in intestinal metaplasia, we conclude that MUC5AC expression may be used as a marker of gastric differentiation. This assumption is further supported by the finding of MUC5AC immunoreactivity in most diffuse carcinomas, which usually display morphologic and histochemical signs of gastric differentiation. The expression of MUC5AC in early gastric carcinomas, regardless of their histologic type, suggests that all gastric carcinomas retain at least some cells with a gastric phenotype during the first steps of neoplastic development.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0020-7136
pubmed:author
pubmed:issnType
Print
pubmed:day
20
pubmed:volume
74
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
112-21
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:9036879-Amino Acid Sequence, pubmed-meshheading:9036879-Animals, pubmed-meshheading:9036879-Antibodies, Monoclonal, pubmed-meshheading:9036879-Blotting, Western, pubmed-meshheading:9036879-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:9036879-Female, pubmed-meshheading:9036879-Gastric Mucosa, pubmed-meshheading:9036879-Glycosylation, pubmed-meshheading:9036879-Humans, pubmed-meshheading:9036879-Immunohistochemistry, pubmed-meshheading:9036879-Intestinal Mucosa, pubmed-meshheading:9036879-Metaplasia, pubmed-meshheading:9036879-Mice, pubmed-meshheading:9036879-Mice, Inbred BALB C, pubmed-meshheading:9036879-Molecular Sequence Data, pubmed-meshheading:9036879-Mucin 5AC, pubmed-meshheading:9036879-Mucins, pubmed-meshheading:9036879-Peptide Fragments, pubmed-meshheading:9036879-Reference Values, pubmed-meshheading:9036879-Stomach Neoplasms, pubmed-meshheading:9036879-Tumor Markers, Biological
pubmed:year
1997
pubmed:articleTitle
Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody.
pubmed:affiliation
Institute of Molecular Pathology and Immunology of the University of Porto, IPATIMUP, Portugal.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't